Figure 1.
Molecular structure of tetrahydrolipstatin (orlistat) and the structural features modified in this study. Modifications were made to reduce the overall hydrophobicity of the compounds and then tested for retention of activity. Several compounds with variation at one or a combination of these features were shown to have increased potency toward FASTE in a fluorogenic biochemical assay.